First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin. - Wikidata - wikimedia - TriplyDB

First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin.

First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin.

http://www.wikidata.org/entity/Q40580831

about

Interventions for preventing oral mucositis for patients with cancer receiving treatment Interventions for preventing oral mucositis for patients with cancer receiving treatment Interventions for preventing oral mucositis for patients with cancer receiving treatment Clinical management of localized colon cancer with capecitabine Relationship between cyclooxygenase 8473T>C polymorphism and the risk of lung cancer: a case-control study.Treatment of colorectal cancer in the elderly Review of systemic therapies for locally advanced and metastatic rectal cancer Management of locally advanced and metastatic colon cancer in elderly patients Evaluating predictive pharmacogenetic signatures of adverse events in colorectal cancer patients treated with fluoropyrimidines A candidate gene study of capecitabine-related toxicity in colorectal cancer identifies new toxicity variants at DPYD and a putative role for ENOSF1 rather than TYMS Decision-making in geriatric oncology: systemic treatment considerations for older adults with colon cancer.Oral drugs in the treatment of metastatic colorectal cancer.Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials Capecitabine in combination with mitomycin C in patients with gastrointestinal cancer: results of an extended multicentre phase-I trial Pilot study of postoperative adjuvant chemoradiation for advanced gastric cancer: adjuvant 5-FU/cisplatin and chemoradiation with capecitabine.A phase II study of capecitabine and oral leucovorin as a third-line chemotherapy in patients with metastatic colorectal cancer.A Muti-center, Randomized Phase II Study of Oxaliplatin and S-1 versus Capecitabine and Oxaliplatin in Patients with Metastatic Colorectal Cancer.Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer Identification of genetic variants associated with capecitabine-induced hand-foot syndrome through integration of patient and cell line genomic analyses Targeting cancers in the gastrointestinal tract: role of capecitabine Maintenance therapy with capecitabine in patients with locally advanced unresectable pancreatic adenocarcinoma Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study.Long-term results from a randomized phase II trial of neoadjuvant combined-modality therapy for locally advanced rectal cancer Capecitabine in gastric cancer.A phase I study of sunitinib plus capecitabine in patients with advanced solid tumors Placebo-controlled trial to determine the effectiveness of a urea/lactic acid-based topical keratolytic agent for prevention of capecitabine-induced hand-foot syndrome: North Central Cancer Treatment Group Study N05C5.Chemotherapy for colorectal cancer.Neoadjuvant capecitabine, bevacizumab and radiotherapy for locally advanced rectal cancer: results of a single-institute Phase I study.Toxicity associated with capecitabine plus oxaliplatin in colorectal cancer before and after an institutional policy of capecitabine dose reduction A randomized multicenter phase II study comparing capecitabine with irinotecan or cisplatin in metastatic adenocarcinoma of the stomach or esophagogastric junction.Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy.Capecitabine plus oxaliplatin compared with 5-fluorouracil plus oxaliplatin in metastatic colorectal cancer: Meta-analysis of randomized controlled trials.Phase II study of single agent capecitabine in the treatment of metastatic non-pancreatic neuroendocrine tumours S-1-based chemotherapy versus capecitabine-based chemotherapy as first-line treatment for advanced gastric carcinoma: a meta-analysis.Comparison of the efficacy and safety of S-1-based and capecitabine-based regimens in gastrointestinal cancer: a meta-analysis Adjuvant therapy for rectal cancer--the transatlantic view.Patients' self-reported adherence to capecitabine on XELOX treatment in metastatic colorectal cancer: findings from a retrospective cohort analysis.Phase II multi-center clinical study on using S-1 to treat advanced breast cancer after resistance to anthracycline and taxane drugs in Chinese patients Postoperative Capecitabine with Concurrent Intensity-Modulated Radiotherapy or Three-Dimensional Conformal Radiotherapy for Patients with Stage II and III Rectal Cancer.Oral Xeloda plus bi-platinu two-way combined chemotherapy in treatment of advanced gastrointestinal malignancies

P2860

Q24235217-33CFA8C9-6F1D-4EF9-8DE4-3FA5D02050DB Q24235482-CAF21400-3F1C-4697-BA38-78BF11773A3A Q24243046-880884CC-B086-40D1-850B-6510FC38D450 Q24611758-79FE89AB-3E93-4D20-BBF4-21593E418CB6 Q25257445-5E5E23C1-562F-4390-9D2B-93F8DF06BF1D Q26781457-4A041754-1121-4953-9C20-6351371CFFB7 Q27021105-A2BB51C2-A4A9-44E8-971E-E873F899FB07 Q27026129-E4515519-C4A6-4507-91E8-4F3BDD815143 Q28534572-436D7770-5C79-444C-8D0D-3929821F8604 Q28652720-2F10E5AD-3C3F-44F3-856F-5C5CDC672EC8 Q30244769-CEAA58AC-96F4-486C-ACF5-65322D7B84B8 Q30251387-49FD2833-F917-4BE0-87EA-A2CA9B46253E Q30913489-31103A47-21B4-498E-B70F-60F28033C7A8 Q33361603-D4FCA873-E987-431B-B752-994F8D749729 Q33370303-BE0821FD-DC2E-4FD8-A54D-B08DB5D59BEC Q33420046-E04F8F22-5B71-42BA-9013-17FEF7C112FE Q33425826-18CF6DA1-E292-418E-9F43-D5FEE71501AE Q33620052-8997D9DC-4FB6-42B9-BB19-342AAFB093EF Q33825180-6B46CD2F-3D27-4DB9-8250-6CD9443AB701 Q33916021-D8F1FFAF-2B35-427F-86B5-55CD30F46B18 Q33967458-E40C9356-3259-47A3-A87D-E900FDFE77B0 Q34006430-C3890FD1-C51E-4909-BEFD-A5C3753E2C84 Q34202729-5464EED3-8A54-40C8-BE84-6C89AB4F08A7 Q34236005-A72ED09E-9403-4717-B548-704F6ECA469C Q34334959-BA74018A-14B6-44F3-96DA-3AAA95BDD09C Q34488678-06E3D8F4-CDCE-4635-AF8E-FAB99AD6B2AC Q34494672-2A174692-1B6B-49D5-9BCC-FCD7581684C0 Q34500981-FCCACB5F-BFB1-47EA-8EF0-D9E3486B3AC0 Q34577462-555C6AD2-CA4F-4533-BEFF-0BECBB0B6773 Q34609932-15B16EB4-8477-476B-AA07-13930FC7B2D7 Q34632080-3EE95CEB-BA68-45BA-8916-29ADAF1C194B Q34639725-CDFAB9F0-125D-4FE6-9D84-30FA3E7CCF7E Q34746009-1FC452AE-4024-40B6-BC0A-9BBD3B6C3EBE Q35070531-3A0B5EC4-FBD8-401B-BF73-C5447EBD08E7 Q35083334-FDA0C77D-0784-43E8-BCE1-42A536EE86DF Q35202155-6DF7C46C-20A4-4E01-940B-BB2668CD45DC Q35444531-E75553B7-99FD-4831-9579-F8EE9A5E41B4 Q35482173-2E646F9C-2EBF-461F-9862-77C951102C74 Q35542484-91F4AAFB-3A97-4EA7-AACF-CC767FA25674 Q35615863-BCBE2CDA-DD84-4C51-8D8A-5AAF605223D9

P2860

First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin.

http://www.wikidata.org/entity/Q40580831

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

First-line oral capecitabine t ...... ous 5-fluorouracil/leucovorin.

@en

First-line oral capecitabine t ...... ous 5-fluorouracil/leucovorin.

@en-gb

type

label

First-line oral capecitabine t ...... ous 5-fluorouracil/leucovorin.

@en

First-line oral capecitabine t ...... ous 5-fluorouracil/leucovorin.

@en-gb

prefLabel

First-line oral capecitabine t ...... ous 5-fluorouracil/leucovorin.

@en

First-line oral capecitabine t ...... ous 5-fluorouracil/leucovorin.

@en-gb

P1433

Q40580831-827B42ED-2E93-4E33-8B65-B5499047E892

P1476

Q40580831-C6F69D21-FE5B-4604-A68D-52A492597932

P2093

Q40580831-004DA6CF-6BBF-4675-AF59-1780EB7A46D5

Q40580831-03C872A5-331F-4824-8E69-2907D3853D3C

Q40580831-1F784673-96D9-44CC-BB61-E5E90EE633FA

Q40580831-32FEEB92-DA96-429D-A7F1-1405AC56DD2A

Q40580831-4305F9F7-28C6-41CB-BF6C-6B35840F9290

Q40580831-45FE9160-390C-46C0-8079-7ED1C3B96DEC

Q40580831-4D42091F-998E-41A5-91EC-C6B9E0BE0D51

Q40580831-640DBEB1-0A35-4715-A046-B2A4664ADEF7

Q40580831-9D0470B3-1014-45BF-AD09-56237F16C6F7

Q40580831-9D7A8769-E34C-447C-9210-2E9EEF2E0ABE

P304

Q40580831-C4ED6E2A-9203-49FD-9488-16ED43575D80

P31

Q40580831-6C821A22-AB6C-4B83-851C-B95941C33EAD

P356

Q40580831-B7EBDABB-22FD-4687-BCCB-4F33A3E66B3A

P433

Q40580831-0D502BAC-9F4B-4622-AA8D-FF443A8F3F88

P478

Q40580831-E1715B8B-2689-4ADD-8D1C-750D34A473F7

P50

Q40580831-A0CB95F3-C439-4A4C-B9FA-C3BB2B54DF26

P577

Q40580831-8EA8509C-8D1D-4A23-AD9B-081703D16720

P5875

Q40580831-05A0A7AC-260B-4F3C-B04C-B67002CA1B18

P698

Q40580831-653CB740-782D-4C8E-BE0B-3CF3CAAD9110

P921

Q40580831-0EB5557A-FB4A-4D48-BE18-1F58351038AB

P356

P1433

Annals of Oncology

P1476

First-line oral capecitabine t ...... ous 5-fluorouracil/leucovorin.

@en

P2093

A Garin

http://www.w3.org/2001/XMLSchema#string

B Osterwalder

http://www.w3.org/2001/XMLSchema#string

C Twelves

http://www.w3.org/2001/XMLSchema#string

Capecitabine Colorectal Cancer Study Group

http://www.w3.org/2001/XMLSchema#string

E Bajetta

http://www.w3.org/2001/XMLSchema#string

E Van Cutsem

http://www.w3.org/2001/XMLSchema#string

G Pérez-Manga

http://www.w3.org/2001/XMLSchema#string

J Cassidy

http://www.w3.org/2001/XMLSchema#string

J Maroun

http://www.w3.org/2001/XMLSchema#string

J Marshall

http://www.w3.org/2001/XMLSchema#string

P304

566-575

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ANNONC/MDF089

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11316843

http://www.w3.org/2001/XMLSchema#string

P698

12056707

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer